Stifel Starts Gracell Biotechnologies Inc (GRCL) at Buy, 'Bullish Into Dual Targeting CD19xBCMA CAR T Data In SLE'
Tweet Send to a Friend
(Updated - October 18, 2023 4:10 PM EDT)
Stifel analyst Ben Burnett initiates coverage on Gracell Biotechnologies Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Ben Burnett initiates coverage on Gracell Biotechnologies Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
